Bullectomy used to treat a patient with pulmonary vesicles related to COVID-19: A case report

Figure 1 Perioperative laboratory tests on patient underwent surgery. A: Perioperative blood routine results showed that COVID-19 patient with pulmonary vesicles showed higher rate of infections, fewer platelets, more neutrophils and fewer lymphocytes. B: After receiving surgery, the TLC and I/CLC in the patient’s circulating blood showed a “W-shaped” curve, NK cells and BLC showed an “M-shaped” curve, H/I LC showed a trend of increasing gradually, and cytoknes (IL-2, 4, 6, 10, Interferon γ, TNF α) showed an upward trend as a whole. C: The level of circulating estrogen was higher than the normal range, while the level of ACE was in the normal range. The COVID-19 patient with pulmonary vesicles showed varying degrees of liver and kidney damage, mild body temperature elevation, and large changes in fluid intake and output. D: 20 d before bullectomy, the chest CT scans of the patient showed changes in small vesicles in the lung. E: Chest X-ray, before bullectomy. F: Chest X-ray, after bullectomy. G: The pulmonary vesicles of the patient during the bullectomy. H: A common pulmonary bulla. NR: Normal range; PCT: Procalcitonin; TLC: T lymphocyte; BLC: B lymphocyte; I/CLC: Inhibition/cytotoxic T lymphocytes; NK cells: Natural killer cells; H/I LC: Helper/inducible T lymphocytes.